Buspirone Hydrochloride Tablet
Product Images NDC 0904-7121

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 0904-7121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (8003b5ed 2f62 4347 A39a 5dfdef3e1084 01)

Chemical structure of Buspirone Hydrochloride depicted in a two-dimensional molecular diagram, showing its specific ring structures and bonds.*

FDA Label Image

Logo (8003b5ed 2f62 4347 A39a 5dfdef3e1084 02)

FDA Label Image

Logo (8003b5ed 2f62 4347 A39a 5dfdef3e1084 03)

FDA Label Image

Image 1 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 04)

Image shows four Buspirone Hydrochloride tablets with imprint codes indicating strengths of 5 mg and 25 mg. The 5 mg tablets are marked with '5' three times, and the 25 mg tablet is marked with 'HP' and '25'. Tablets appear to be scored and are likely oral dosage form by Major Pharmaceuticals.*

FDA Label Image

Image 2 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 05)

Tablet imprinted with '5' on both sides of a scored line, indicating a 5 mg oral tablet of Buspirone Hydrochloride, manufactured by Major Pharmaceuticals.*

FDA Label Image

Image 3 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 06)

FDA Label Image

Image 4 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 07)

A partial blister packaging image displaying a single tablet marked with the number '5'. The tablet is round and white, positioned within a capsule-shaped clear blister cavity.*

FDA Label Image

Image 5 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 08)

Image showing three white tablets of Buspirone Hydrochloride, each with an imprint of the number '5'. The tablets are square-shaped and held between fingers, aligned side-by-side, indicating the 5 mg strength. The labeler Major Pharmaceuticals is associated with these oral tablets.*

FDA Label Image

Image 6 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 09)

Buspirone Hydrochloride 10 mg oral tablets imprint side showing two variations: one oblong tablet scored and marked with 'HP 97', and one rectangular tablet scored into three segments each marked with '10'. The tablets denote the 10 mg strength and are from Major Pharmaceuticals.*

FDA Label Image

Image 7 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 10)

Buspirone Hydrochloride 10 mg oral tablet with imprint '10 10' on one side, scored in the middle. The tablet is shown split in half, indicating it can be divided. Labeler is Major Pharmaceuticals.*

FDA Label Image

Image 8 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 11)

FDA Label Image

Image 9 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 12)

The image shows an imprint on a tablet with the number '10' inside an oval shape. This corresponds to Buspirone Hydrochloride 10 mg oral tablet, labeled by Major Pharmaceuticals.*

FDA Label Image

Image 10 (8003b5ed 2f62 4347 A39a 5dfdef3e1084 13)

Buspirone Hydrochloride 10 mg oral tablets shown, with two tablets marked with "10" imprinted on one side. The tablets are white and rectangular, and held between fingers, illustrating the size and imprint of the dosage form produced by Major Pharmaceuticals.*

FDA Label Image

Logo (8003b5ed 2f62 4347 A39a 5dfdef3e1084 14)

FDA Label Image

Logo (8003b5ed 2f62 4347 A39a 5dfdef3e1084 15)

FDA Label Image

Carton Label (8dc1ee33 E5aa 4462 8fb9 9bbdf5463488 00)

Buspirone Hydrochloride 10 mg oral tablets by Major Pharmaceuticals. The label shows unit dose packaging containing 100 tablets. It includes directions for pharmacists to dispense with patient information leaflet. The label also provides dosage, storage information, warnings, and distributor details.*

FDA Label Image

Carton Label (8dc1ee33 E5aa 4462 8fb9 9bbdf5463488 01)

Buspirone Hydrochloride tablets, USP 5 mg, oral unit dose packaging from Major Pharmaceuticals. The label states 100 tablets per package, with directions for pharmacists to dispense with patient information leaflets. Storage instructions specify controlled room temperature. The label includes NDC 0904-7122-61 and manufacturer details of Major Pharmaceuticals, Livonia, MI, and Avet Pharmaceuticals Inc., East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.